�Flexible Stenting Solutions Inc., a leading developer of third genesis peripheral arterial stents, proclaimed that a physician at Auckland City Hospital in New Zealand successfully ingrained several of its third base generation arterial stents for the intervention of peripheral vascular lesions involving the superficial femoral and popliteal arteries. Patients with lesion lengths up to century mm and fully occluded lesions were included in the study.
This first-in-man clinical trial using a full range of a function of stent sizes, including 120 mm, was performed by Associate Professor Andrew Holden wHO is the Director of Interventional Radiology at Auckland City Hospital, and the principal police detective. "The flexible stent handled both stenoses and occlusions in the femoro-popliteal artery segment as well as I had hoped with excellent immediate appearances following deployment" said Professor Holden. "Overall, I felt the stent and delivery system performed very well in the sharp phase and I look the longer term comply up in these patients with great interest.
Flexible Stenting Solutions Inc. has developed a novel, self-expanding stent engineering to provide a wide range of vascular and non-vascular therapies. The treatment of femoro-popliteal disease is the offset vascular coating of Flexible Stenting Solutions' technology. "We believe the FlexStent represents a true third multiplication SFA/Pop stent and delivery system that can significantly improve patient care in the high growth peripheral vascular section." said Janet Burpee, CEO of Flexible Stenting Solutions Inc. "Given the results of this study we intend to pursue a comprehensive regulatory and commercial development strategy."
While stent procedures accept become widespread in the treatment of coronary arterial disease, their use in the more challenging peripheral vascular disease setting had been limited in the last several years by inadequate stent design. The fully connected SFA/Pop flexile stent has coupled engineering with clinical needs by providing a highly long-lasting and fatigue resistant stent with superior radial rigour and low chronic outward force. The delivery system promotes simplicity, ease-of-use and accurate placement for the vascular medico.
About Flexible Stenting Solutions Inc. Flexible Stenting Solutions Inc. is a leading developer of third propagation flexible peripheral arterial stents. The Company's lead product candidate is a self-expanding stent specifically designed for the rough loading conditions present in the prevalent sites of peripheral vascular disease in the glower extremity. The FlexStent leverages state of the graphics technology with the integration of helically wound struts with voluted flexible coils providing a mechanism optimized for vigorous applications, while allowing ease of use and positioning for the vascular mD.
Flexible Stenting Solutions Inc.
More info
